Oxandrolone: Anabolic steroid use in HIV positive women

Pharo, Anne; Salvato, Patricia; Vergel, Nelson; Carroll, Evelyn L.; Sauer, LeonardA.; Mp, Mooney

doi:10.1016/s0899-9007(97)82622-6

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings are consistent with previous reports on the relative safety and efficacy of oxandrolone to promote weight and lean tissue gains in HIV-infected individuals. 38,[41][42][43][44][45] Our study is unique among other studies of oxandrolone in that we have conducted a more comprehensive evaluation of both body composition and quality of life changes over a course of treatment.…”

Section: Discussionmentioning

confidence: 99%

“…2 Oxandrolone is an orally administered testosterone derivative with a favorable anabolic:androgen ratio and safety profile that has been demonstrated to promote weight and lean tissue gains with a minimization of adverse side effects in HIV-infected individuals. 1,38,[41][42][43][44][45][46] However, there is a deficit in the existing literature on oxandrolone in terms of its ability to impact the specific subcomponent of the lean tissue compartment most related to nutritional status, the BCM.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Body cell mass repletion and improved quality of life in HIV‐infected individuals receiving oxandrolone

Earthman

Reid

Harper

et al. 2002

J Parenter Enteral Nutr

View full text Add to dashboard Cite

This is the first study involving oxandrolone therapy in HIV infection to document changes in quality of life and BCM, the metabolically active component of lean body mass that reflects nutritional status better than other more global body composition parameters. Nutritional status and quality of life can improve in HIV-infected individuals receiving a combined therapeutic approach that includes oxandrolone.

show abstract